SBI funds $1 billion for Sun Pharma's US acquisition

SBI funds $1 billion for Sun Pharma's US acquisition. This funding supports Sun Pharma’s major overseas expansion, marking one of the largest pharma deals by an Indian company. The $1 billion infusion underscores strong banking support for strategic acquisitions. Such a significant move could enhance Sun Pharma’s global footprint and revenue potential.

📊 STOCKS: SUNPHARMA | 🏢 SECTOR: Pharma | #HIGHIMPACT #Acquisition